Key Financial Data Of Reporting Company

AFC-HD AMS Life Science Co.,Ltd. - Filing #7341214

Concept 2023-09-01 to
2024-02-29
As at
2024-02-29
2023-12-01 to
2024-02-29
2022-09-01 to
2023-08-31
As at
2023-08-31
As at
2023-02-28
2022-09-01 to
2023-02-28
2022-12-01 to
2023-02-28
Key financial data of reporting company
Business results of reporting company
Net sales
14,542,980,000 JPY
25,579,009,000 JPY
12,444,800,000 JPY
Ordinary profit (loss)
1,060,201,000 JPY
1,654,107,000 JPY
708,241,000 JPY
Net assets
13,631,707,000 JPY
13,157,452,000 JPY
12,644,959,000 JPY
Total assets
44,311,395,000 JPY
41,071,748,000 JPY
38,953,015,000 JPY
Basic earnings (loss) per share
45.79
22.99
78.51
29.46
18.01
Diluted earnings per share
45.74
78.46
29.45
Equity-to-asset ratio
0.307 xbrli:pure
0.319 xbrli:pure
0.323 xbrli:pure
Net cash provided by (used in) operating activities
-264,847,000 JPY
865,280,000 JPY
397,356,000 JPY
Net cash provided by (used in) investing activities
-1,354,435,000 JPY
-1,946,009,000 JPY
-791,130,000 JPY
Net cash provided by (used in) financing activities
707,537,000 JPY
1,881,171,000 JPY
923,657,000 JPY
Cash and cash equivalents
10,154,370,000 JPY
11,062,021,000 JPY
10,785,778,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.